HMPV vs. COVID-19: Understanding Differences and Dangers
HMPV and COVID-19 are respiratory viruses with notable differences in symptoms, spread, and risks.
What is HMPV?
Human metapneumovirus (HMPV) causes respiratory infections, from mild to severe. Discovered in 2001, it peaks in winter and spring and can be serious for vulnerable groups.
Symptoms of HMPV
HMPV symptoms include cough, fever, and congestion. Severe cases in children and immunocompromised people may cause wheezing, respiratory distress, or pneumonia.
HMPV vs COVID 19
HMPV causes mild respiratory symptoms and spreads less easily. COVID-19 affects multiple systems and has a higher risk of severe complications.
Who is at risk?
Infants, young children, the elderly, and those with weak immunity or chronic conditions are most at risk of severe HMPV infections.
How HMPV Spreads
HMPV spreads through respiratory droplets and contaminated surfaces. Good hygiene and distancing help prevent infection.
Diagnosis and Treatment
HMPV is diagnosed with PCR tests. Treatment includes symptom relief with antipyretics, antihistamines, oxygen therapy, or nebulization if needed.
Prevention Tips
Wash hands often, cover coughs, wear masks, and disinfect surfaces to prevent HMPV spread. Avoid close contact with sick individuals.
HMPV and COVID-19 differ but can harm vulnerable people. Stay informed, practice prevention, and consult a doctor if symptoms worsen.